You will need to login first in order to enroll or view an activity. Login Here
Reducing Complications of Therapeutic Blood Transfusion in Sickle Cell Disease
Transfusion is an established therapy in sickle cell disease. It can treat and prevent certain disease complications, reducing morbidity and mortality; but there are unique aspects of transfusing individuals with sickle cell disease that must be taken into consideration to maximize benefits and minimize complications. In 2014, the National Heart Lung and Blood Institute of the National Institutes of Health released an expert panel report on sickle cell disease management that includes evidence-based recommendations for transfusion and the avoidance and management of transfusion complications. In addition, guidelines from Great Britain were published in 2017 addressing laboratory and clinical management of transfusion in sickle cell disease. This course presents these and other important aspects of quality, effective care for individuals with sickle cell disease.
Activities are designed to increase knowledge and change competency of transfusion practices and strategies for individuals with hemoglobin disorders. Content is derived from actual peer-reviewed publications.
Introduction
Module 1. Use of Transfusion During Acute Illness (WD2943)
Module 2. Delayed Hemolytic Transfusion Reactions (WD2944)
Module 3. Management of Chronic Transfusion (WD2945)
DOs, MDs, NPs, PAs
Introduction
Module 1. Use of Transfusion During Acute Illness (WD2943)
Module 2. Delayed Hemolytic Transfusion Reactions (WD2944)
Module 3. Management of Chronic Transfusion (WD2945)
Origination Date: August 25, 2017
Renewal Date: October 16, 2019
Expiration Date: October 16, 2021
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
There are no fees for participating in and receiving credit for this activity. In order to receive credit,
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Centers for Disease Control and Prevention and Georgia State University.
The Centers for Disease Control and Prevention, Emory University School of Medicine, and Georgia State University are jointly providing the CNE for this activity.
CME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Centers for Disease Control and Prevention and Georgia State University. The Centers for Disease Control and Prevention is accredited (by the ACCME) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education (CNE) by the American Nurses Credentialing Center's Commission on Accreditation.
Please view individual training videos for information on accreditation and contact hours.
CDC did not accept commercial support for this continuing education activity.
Development of this course was supported by Cooperative Agreement DD14-1406, funded by the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or Department of Health and Human Services.
If you have any questions about this activity, please contact Mary Hulihan PhD, Health Scientist, Epidemiology and Surveillance Branch, Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, at 404-498-6724.
The Partners in Bleeding Disorders Education Program is supported by educational grants from Takeda Pharmaceuticals U.S.A, Inc.; Genentech, a member of the Roche Group; and the National Hemophilia Foundation (NHF).
Copyright © 2022 Indiana Hemophilia & Thrombosis Center. All rights reserved. Privacy Policy | Travel Policy | Terms of Service Credits